当前位置：
X-MOL 学术
›
Cancer Biother. Radiopharm.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database
Cancer Biotherapy and Radiopharmaceuticals ( IF 3.4 ) Pub Date : 2021-07-23 , DOI: 10.1089/cbr.2020.3798 Dan Li 1, 2 , Si-Hong Liu 2, 3 , Qiong-Yao Liu 1, 2 , Qing-Qing Zou 1, 2 , Lin Lv 1, 2 , Guo-Long Liu 1, 2 , Yong Wu 1, 2
Cancer Biotherapy and Radiopharmaceuticals ( IF 3.4 ) Pub Date : 2021-07-23 , DOI: 10.1089/cbr.2020.3798 Dan Li 1, 2 , Si-Hong Liu 2, 3 , Qiong-Yao Liu 1, 2 , Qing-Qing Zou 1, 2 , Lin Lv 1, 2 , Guo-Long Liu 1, 2 , Yong Wu 1, 2
Affiliation
Objective: This study investigated the expression and clinical value of hsa-miR-504 in cervical cancer and its possible mechanism of regulating the progress of cervical cancer.
中文翻译：
基于癌症基因组图谱数据库分析hsa-miR-504在宫颈癌中的作用及调控机制
目的：本研究探讨hsa-miR-504在宫颈癌中的表达及临床价值及其调控宫颈癌进展的可能机制。
更新日期：2021-07-28
中文翻译：
基于癌症基因组图谱数据库分析hsa-miR-504在宫颈癌中的作用及调控机制
目的：本研究探讨hsa-miR-504在宫颈癌中的表达及临床价值及其调控宫颈癌进展的可能机制。
京公网安备 11010802027423号